SARS-CoV-2 ORF3a protein

Also Known As:

ORF3a protein, SARS-CoV-2; ORF3a protein, 2019 novel coronavirus; ORF3a protein, 2019-nCoV; ORF3a protein, COVID-19 virus; ORF3a protein, COVID19 virus; ORF3a protein, severe acute respiratory syndrome coronavirus 2

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Viral Proteins: 4250
    - Viral Structural Proteins: 171
      - Viral Envelope Proteins: 291
        Viroporin Proteins: 74
        SARS-CoV-2 ORF3a protein: 2

Related Diseases

1.	Inflammation (Inflammations) 05/30/2023 - "Inhibition of PERK Kinase, an Orchestrator of the Unfolded Protein Response (UPR), Significantly Reduces Apoptosis and Inflammation of Lung Epithelial Cells Triggered by SARS-CoV-2 ORF3a Protein."
2.	Infections 11/01/2023 - "This suggests, inhibiting SARS-CoV-2 ORF3a protein is a good therapeutic strategy for the treatment in COVID-19 infection by promoting the host immune defense mechanism."
3.	COVID-19 11/01/2023 - "This suggests, inhibiting SARS-CoV-2 ORF3a protein is a good therapeutic strategy for the treatment in COVID-19 infection by promoting the host immune defense mechanism."

Related Drugs and Biologics

1.	PERK kinase